Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
2501
CALL
DELISTED
Ansys
ANSS
| $13.1M | ﹤0.01% |
37,800
-28,600
| -43% | -$9.89M |
|
2502
PUT
Fluor
FLR
$7.09B
| $13.1M | ﹤0.01% |
738,900
+10,400
| +1% | +$214K |
|
|
CMA
2503
CALL
DELISTED
Comerica
CMA
| $13.1M | ﹤0.01% |
183,300
-97,600
| -35% | -$7.23M |
|
2504
O'Reilly Automotive
ORLY
$71.5B
| $13.1M | ﹤0.01% |
346,290
-7,815
| -2% | -$280K |
|
2505
Alaska Air
ALK
$4.77B
| $13.1M | ﹤0.01% |
216,680
+159,155
| +277% | +$10.7M |
|
2506
CALL
Zimmer Biomet
ZBH
$19.2B
| $13M | ﹤0.01% |
83,533
-10,815
| -11% | -$1.75M |
|
2507
NetApp
NTAP
$37.6B
| $13M | ﹤0.01% |
159,254
+79,299
| +99% | +$6.19M |
|
2508
T. Rowe Price
TROW
$24B
| $13M | ﹤0.01% |
65,783
+21,134
| +47% | +$3.95M |
|
2509
CALL
OneMain Financial
OMF
$7.29B
| $13M | ﹤0.01% |
217,100
+131,100
| +152% | +$7.42M |
|
2510
CALL
iShares MSCI China ETF
MCHI
$6.21B
| $13M | ﹤0.01% |
157,700
-105,600
| -40% | -$8.6M |
|
2511
PUT
Wabtec
WAB
$50.2B
| $13M | ﹤0.01% |
157,900
+30,700
| +24% | +$2.49M |
|
2512
CALL
GoodRx Holdings
GDRX
$1.22B
| $13M | ﹤0.01% |
360,800
+101,800
| +39% | +$3.76M |
|
2513
AvePoint
AVPT
$2.96B
| $13M | ﹤0.01% |
1,060,347
+225,382
| +27% | +$2.46M |
|
2514
Acadia Pharmaceuticals
ACAD
$5.07B
| $13M | ﹤0.01% |
531,974
+290,358
| +120% | +$6.55M |
|
2515
Sempra
SRE
$55B
| $13M | ﹤0.01% |
195,796
+33,182
| +20% | +$2.27M |
|
2516
Virtu Financial
VIRT
$5.84B
| $12.9M | ﹤0.01% |
468,682
-56,456
| -11% | -$1.68M |
|
2517
PUT
Cencora
COR
$61.6B
| $12.9M | ﹤0.01% |
113,100
-20,500
| -15% | -$2.42M |
|
2518
PUT
Bunge Global
BG
$21.5B
| $12.9M | ﹤0.01% |
165,600
+44,600
| +37% | +$3.77M |
|
2519
PUT
Ormat Technologies
ORA
$6.38B
| $12.9M | ﹤0.01% |
186,000
+154,900
| +498% | +$11M |
|
2520
CALL
Stellantis
STLA
$19.8B
| $12.9M | ﹤0.01% |
655,900
+515,100
| +366% | +$9.68M |
|
|
CRON
2521
CALL
Cronos Group
CRON
$1.32B
| $12.9M | ﹤0.01% |
1,503,200
-62,500
| -4% | -$517K |
|
2522
Live Nation Entertainment
LYV
$42.5B
| $12.9M | ﹤0.01% |
147,587
+76,452
| +107% | +$6.55M |
|
2523
PUT
Inovio Pharmaceuticals
INO
$132M
| $12.9M | ﹤0.01% |
116,192
+13,900
| +14% | +$1.34M |
|
2524
CALL
Park Hotels & Resorts
PK
$3.2B
| $12.9M | ﹤0.01% |
627,100
-355,800
| -36% | -$7.62M |
|
2525
Schrodinger
SDGR
$1.47B
| $12.9M | ﹤0.01% |
170,781
+46,478
| +37% | +$3.37M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.